AzTrials
AzTrials

Hip FracturesNCT05969561

Emergency Physician-performed Ultrasound-guided Femoral Nerve Blocks in Patients With Hip Fractures.

A study testing ultrasound-guided femoral nerve block and Intravenous or intramuscular pain medication in people with Hip Fractures, run by National Taiwan University Hospital at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In this prospective study, emergency physicians perform ultrasound-guided femoral nerve block for patients with hip fractures. We compare the effectiveness of analgesia and patient satisfaction of ultrasound-guided femoral nerve block with liberal use of the pain medicine in the emergency department. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Hip Fractures
What is being tested?
ultrasound-guided femoral nerve block and Intravenous or intramuscular pain medication
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
80 participants
Where
1 siteTaiwan
Study dates
3 Jul 2023to 30 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients older than 20-year-old with hip fractures
  • Stay in the emergency department for at lease two hours

Who cannot join

  • hemodynamic unstable
  • major trauma in addition to hip fractures
  • the use of any pain management before the arrival of emergency department
  • chronic opioid use
  • inability to understood the numerical rating scale after instruction
  • allergy to local anesthetics
  • coagulopathy
  • injection site infection

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site, 1 recruiting
  • NTUH Yunlin Branch

    Douliu, Yunlin County, 640

    YILIN LEE, +886972655633, leeatntuh@gmail.com

    Recruiting

Other trials in Taiwan

About this study

Official title: Ultrasound-Guided Femoral Nerve Block

In this prospective study, emergency physicians perform ultrasound-guided femoral nerve block for patients with hip fractures. We compare the effectiveness of analgesia and patient satisfaction of ultrasound-guided femoral nerve block with liberal use of the pain medicine in the emergency department. The primary outcome is the assessment of time to relief the pain with fewer adverse effects and less rescue pain medication use. The secondary outcome is patient satisfaction and adverse effects for different method of pain control.

Read the detailed description

The aim of this study is to compare the effectiveness of ultrasound-guided femoral nerve blocks performed by emergency physicians for pain control in the emergency department with traditional pain medicine.

This study is a prospective before-and-after design. The enrollees are 20-year-old and older adult patients with hip fractures. We use numerical rating scale using a 0-10 scale to assess pain severity at the different time frame after giving pain medicine. The scale zero means "no pain" and scale 10 means "the worst pain imaginable".

The primary outcome is assessed by the reduction of pain scale which are taken on a numeric rating scale every 30 minutes before and after pain management. The secondary outcome compares complications, adverse effects and patient satisfaction for different method of pain control.

Conditions
Hip Fractures
Being tested
ultrasound-guided femoral nerve block, Intravenous or intramuscular pain medication
Keywords
Ultrasound-guided femoral nerve block
Medical subject headings
Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasound-guided femoral nerve blockProcedure or surgery

    The local analgesia is injected and infiltrated around the femoral nerve under ultrasound guidance.

  • Intravenous or intramuscular pain medicationDrug

    Intravenous or intramuscular pain medication is given for patients with hip fracture.

Study groups in NCT05969561
Study groupRoleWhat they receive
Ultrasound-guided femoral nerve blockActive comparatorPatients with hip fractures had underwent Ultrasound-guided femoral nerve block performed by emergency physicians.
Receives: Procedure: ultrasound-guided femoral nerve block
The liberal use of pain medicationSham comparatorPatients with hip fractures had given intravenous or intramuscular opioids or NSAID at the emergency department.
Receives: Drug: Intravenous or intramuscular pain medication

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. a short time of pain relief

    The numerical pain score from 0 to 10 is used to assess pain severity and the scale 0 means no pain and the scale 10 means the worst pain imaginable. The pain score assessed for the leg with hip fracture at rest and with movement will be recorded after different pain medicine and the reduction of pain score at different time frame will be evaluated. The more reduction of pain score, the better.

    Measured: 2 hours

Secondary outcomes (3)
  1. Adverse effects

    Any adverse effects of different pain medication

    Measured: two hours

  2. Patient satisfaction

    The difference of patient satisfaction between ultrasound-guided femoral nerve block and the liberal use of pain medication

    Measured: two hours

  3. Complications of ultrasound-guided femoral nerve block

    Any complications of ultrasound-guided femoral nerve block

    Measured: two hours and one week after ultrasound-guided femoral nerve block or after hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2023
  2. Study start3 Jul 2023
  3. Primary completion5 Mar 2025
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05969561
Sponsor's protocol ID
202211021RINB
Status last verified
Jun 2025
First submitted
23 Jul 2023
Last updated
5 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ultrasound-guided femoral nerve block and Intravenous or intramuscular pain medication in people with Hip Fractures, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact YILIN LEE (+886972655633, leeatntuh@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

a short time of pain relief (time frame: 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in